We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Exact Sciences Corporation
97 own
26 watching
Current Price
$83.84
$0
(0%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
15,076.96M
52-Week High
85.82
52-Week Low
29.27
Average Volume
1.48M
Dividend Yield
--
P/E Ratio
--
Market Capitalization15,076.96M52-Week High85.8252-Week Low29.27Average Volume1.48MDividend Yield--P/E Ratio--What does the Exact Sciences Corporation do?
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has a collaboration, license, and purchase agreement with Genzyme Corporation; and license agreement with MAYO Foundation for Medical Education and Research. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Read More
How much money does Exact Sciences Corporation make?
News & Events about Exact Sciences Corporation.
PR Newswire
1month ago
Exact Sciences schedules first quarter 2023 earnings call Exact Sciences schedules first quarter 2023 earnings call PR Newswire MADISON, Wis., April 10, 2023 MADISON, Wis., April 10, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic...
TheStreet.com - Investing
1month ago
Her flagship Ark Innovation ETF has slumped 38% over the past year, but has rebounded 23% so far this year.Her flagship Ark Innovation ETF has slumped 38% over the past year, but has rebounded 23% so far this year.If youve followed Cathie Woods trades in recent months, youve undoubtedly noticed that...
Zolmax
2 months ago
Exact Sciences (NASDAQ:EXAS Get Rating) had its price objective hoisted by Piper Sandler from $50.00 to $70.00 in a report issued on Friday, The Fly reports. They currently have a neutral rating on the medical research companys stock. A number of other equities research analysts also recently issued...
Ticker Report
3 months ago
Exact Sciences Co. (NASDAQ:EXAS Get Rating) CEO Kevin T. Conroy sold 14,617 shares of Exact Sciences stock in a transaction on Wednesday, February 15th. The stock was sold at an average price of $65.59, for a total value of $958,729.03. Following the completion of the transaction, the chief ...
Zolmax
3 months ago
Exact Sciences Co. (NASDAQ:EXAS Get Rating) CEO Kevin T. Conroy sold 14,617 shares of Exact Sciences stock in a transaction on Wednesday, February 15th. The stock was sold at an average price of $65.59, for a total value of $958,729.03. Following the completion of the transaction, the chief ...
Frequently Asked Questions
Frequently Asked Questions
What is Exact Sciences Corporation share price today?
Can Indians buy Exact Sciences Corporation shares?
How can I buy Exact Sciences Corporation shares from India?
Can Fractional shares of Exact Sciences Corporation be purchased?
What are the documents required to start investing in Exact Sciences Corporation stocks?
What is today’s traded volume of Exact Sciences Corporation?
What is today’s market capitalisation of Exact Sciences Corporation?
What is the 52-Week High and Low Range of Exact Sciences Corporation?
What percentage is Exact Sciences Corporation down from its 52-Week High?
What percentage is Exact Sciences Corporation up from its 52-Week Low?
Current Price
$83.84
$0
(0%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.